Relevium Technologies Inc.

RLV on TSXVToday's ChangeVolume52 Week Range (Low/Hi)Market Cap
0.08CAN -0.01/-5.88%141,0000.05 / 0.269.09 M
RLLVF on OTCQBToday's ChangeVolume52 Week Range (Low/Hi)Market Cap
0.06US -0.00/-5.51%2,2500.05 / 0.257.14 M

Contact Information

Relevium Technologies Inc.

Headquarters:
1000 Sherbrooke St. West, Suite 2700
Montréal, Québec
Canada, H3A 3G4
Tel: 888-528-8687
Email: Send a message
Website: Visit website
For more information...
Lead: Barry Mire

Relevium is a publicly-traded company that operates in the health and wellness industry, including legal cannabis, with a primary focus on online distribution. The principal business of the Company is the identification, evaluation, acquisition and operations of brands and businesses in the Health and Wellness markets and medical cannabis.

The Company pursues its business strategy through an acquisition and partnership model in a holistic approach to encompass a wide range of health and wellness consumer products. Relevium operates through two wholly-owned subsidiaries:

BGX E-Health LLC (BGX): Based in Orlando, Florida, BGX markets dietary supplements, nutraceuticals, sports nutrition and cosmeceuticals primarily through its Bioganix® brand portfolio in the US and Europe. Relevium’s brands such as Bioganix® are sold at some of the world’s largest retailers including such as Walmart.com and Amazon.com.

The Company’s strategy for growing its brands includes expanding its product offering, adding new distribution channels and developing partnerships that add value through exclusive ingredients. BGX is currently testing a complete line of dietary supplements derived from Cannabis with an initial focus on hemp derived, whole plant organic extract rich in CBD (cannabidiol).

Biocannabix Health Corporation (BCX): Based in Montreal, Quebec, BCX is an entrepreneurial venture to establish a vertically integrated research based medical cannabis company in the Nutraceutical space.

Relevium is a publicly-traded company (TSX-V: RLV / OTCQB: RLLVF) that operates in the health and wellness industry, including legal cannabis, with a primary focus on online distribution. The principal business of the Company is the identification, evaluation, acquisition and operations of brands and businesses in the Health and Wellness markets and medical cannabis. The Company pursues its business strategy through an acquisition and partnership model in a holistic approach to encompass a wide range of health and wellness consumer products.

Aurelio Useche -  CEO

Andre Godin - Chairman

Michel Timperio - Director

Aurelio Useche - Director and CEO

Andre Godin - Director and Chairman

Michel Timperio - Director

Tina Sampalis - Director

Pierre Bertrand - Director

Stock Information

Company Overview

Relevium is a publicly-traded company that operates in the health and wellness industry, including legal cannabis, with a primary focus on online distribution. The principal business of the Company is the identification, evaluation, acquisition and operations of brands and businesses in the Health and Wellness markets and medical cannabis.

The Company pursues its business strategy through an acquisition and partnership model in a holistic approach to encompass a wide range of health and wellness consumer products. Relevium operates through two wholly-owned subsidiaries:

BGX E-Health LLC (BGX): Based in Orlando, Florida, BGX markets dietary supplements, nutraceuticals, sports nutrition and cosmeceuticals primarily through its Bioganix® brand portfolio in the US and Europe. Relevium’s brands such as Bioganix® are sold at some of the world’s largest retailers including such as Walmart.com and Amazon.com.

The Company’s strategy for growing its brands includes expanding its product offering, adding new distribution channels and developing partnerships that add value through exclusive ingredients. BGX is currently testing a complete line of dietary supplements derived from Cannabis with an initial focus on hemp derived, whole plant organic extract rich in CBD (cannabidiol).

Biocannabix Health Corporation (BCX): Based in Montreal, Quebec, BCX is an entrepreneurial venture to establish a vertically integrated research based medical cannabis company in the Nutraceutical space.

Relevium is a publicly-traded company (TSX-V: RLV / OTCQB: RLLVF) that operates in the health and wellness industry, including legal cannabis, with a primary focus on online distribution. The principal business of the Company is the identification, evaluation, acquisition and operations of brands and businesses in the Health and Wellness markets and medical cannabis. The Company pursues its business strategy through an acquisition and partnership model in a holistic approach to encompass a wide range of health and wellness consumer products.

Management

Aurelio Useche -  CEO

Andre Godin - Chairman

Michel Timperio - Director

Board of Directors

Aurelio Useche - Director and CEO

Andre Godin - Director and Chairman

Michel Timperio - Director

Tina Sampalis - Director

Pierre Bertrand - Director

Contact Information

Headquarters:
1000 Sherbrooke St. West, Suite 2700
Montréal, Québec
H3A 3G4, Canada
Telephone: 888-528-8687
Email: Send a message
Website: Visit website